Brightgene Bio-medical Technology Co (SHSE:688166) FFO


SHSE:688166 Brightgene Bio-medical Technology Co Ltd SHSE:688166
84 GF Score
Price ¥31.19
GF Value ¥38.49
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Brightgene Bio-medical Technology Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:688166
84GF Score
Brightgene Bio-medical Technology Co Ltd SHSE:688166
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Brightgene Bio-medical Technology Co (SHSE:688166) Overvalued in 2026?

Based on GuruFocus' analysis, Brightgene Bio-medical Technology Co stock appears to be undervalued. The current stock price of ¥31.19 is trading 19% below its estimated GF Value™ of ¥38.49. GuruFocus considers Brightgene Bio-medical Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688166:

  • FFO:
  • GF Value™: ¥38.49 vs. price of ¥31.19 (19% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688166 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Brightgene Bio-medical Technology Co Business Description

Address No. 218 Xinghu Street, Buildings C25-C28, Nanotechnology Park, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215123
Brightgene Bio-medical Technology Co Ltd is engaged in the Research and development and production of pharmaceutical intermediates, active pharmaceutical ingredients and formulations with high technological barriers.
84GF Score

Get the complete analysis for SHSE:688166

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.19
Price
¥38.49
GF Value